BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1197 related articles for article (PubMed ID: 16818951)

  • 21. Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir.
    Deng WP; Wu CC; Lee CC; Yang WK; Wang HE; Liu RS; Wei HJ; Gelovani JG; Hwang JJ; Yang DM; Fu YK; Wu CW
    J Nucl Med; 2006 May; 47(5):877-84. PubMed ID: 16644759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography.
    Tjuvajev JG; Avril N; Oku T; Sasajima T; Miyagawa T; Joshi R; Safer M; Beattie B; DiResta G; Daghighian F; Augensen F; Koutcher J; Zweit J; Humm J; Larson SM; Finn R; Blasberg R
    Cancer Res; 1998 Oct; 58(19):4333-41. PubMed ID: 9766661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
    Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adenovirus-mediated herpes simplex virus thymidine kinase gene transference and combined drug therapy leads to apoptosis of human epithelial ovarian cancer cells].
    Jiang J; Kong B; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):736-9. PubMed ID: 11286034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ¹¹¹In-DOTA-Annexin V for imaging of apoptosis during HSV1-tk/GCV prodrug activation gene therapy in mice with NG4TL4 sarcoma.
    Lin MH; Wu SY; Wang HE; Liu RS; Chen JC
    Appl Radiat Isot; 2016 Feb; 108():1-7. PubMed ID: 26656427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells.
    Balzarini J; Degrève B; Andrei G; Neyts J; Sandvold M; Myhren F; de Clercq E
    Gene Ther; 1998 Mar; 5(3):419-26. PubMed ID: 9614564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression.
    Brust P; Haubner R; Friedrich A; Scheunemann M; Anton M; Koufaki ON; Hauses M; Noll S; Noll B; Haberkorn U; Schackert G; Schackert HK; Avril N; Johannsen B
    Eur J Nucl Med; 2001 Jun; 28(6):721-9. PubMed ID: 11440032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Killing effects of ganciclovir on human pulmonary adenocarcinoma cell A549 transduced with HSV1-TK gene in vitro and in vivo.
    He XL; Guo XJ; Qian GS; He XH; Huang GJ; Chen WZ; Li SP
    Acta Pharmacol Sin; 2001 Oct; 22(10):901-6. PubMed ID: 11749772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibitory effect of ganciclovir on the HSV1-tk positive subcutaneous tumors transplanted with human ovarian cancer in nude mice].
    Xu C; Zhang X; Jin Z
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):709-11. PubMed ID: 9772430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
    Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU.
    Haubner R; Avril N; Hantzopoulos PA; Gansbacher B; Schwaiger M
    Eur J Nucl Med; 2000 Mar; 27(3):283-91. PubMed ID: 10774880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
    Kokoris MS; Sabo P; Adman ET; Black ME
    Gene Ther; 1999 Aug; 6(8):1415-26. PubMed ID: 10467366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.
    Hu WX; Zeng ZJ; Luo SQ; Chen Q
    Chin Med J (Engl); 2004 Mar; 117(3):434-9. PubMed ID: 15043787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y; Gilbert JD; Kim JH; Freytag SO
    Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
    Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM
    Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
    Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
    Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of F-18-labeled 5-iodocytidine (18F-FIAC) as a new potential positron emission tomography probe for herpes simplex virus type 1 thymidine kinase imaging.
    Chan PC; Wu CY; Chang WY; Chang WT; Alauddin M; Liu RS; Lin WJ; Chen FD; Chen CL; Wang HE
    Nucl Med Biol; 2011 Oct; 38(7):987-95. PubMed ID: 21982570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
    Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.